Do you want to publish a course? Click here

Creating Fair Models of Atherosclerotic Cardiovascular Disease Risk

76   0   0.0 ( 0 )
 Added by Stephen Pfohl
 Publication date 2018
and research's language is English




Ask ChatGPT about the research

Guidelines for the management of atherosclerotic cardiovascular disease (ASCVD) recommend the use of risk stratification models to identify patients most likely to benefit from cholesterol-lowering and other therapies. These models have differential performance across race and gender groups with inconsistent behavior across studies, potentially resulting in an inequitable distribution of beneficial therapy. In this work, we leverage adversarial learning and a large observational cohort extracted from electronic health records (EHRs) to develop a fair ASCVD risk prediction model with reduced variability in error rates across groups. We empirically demonstrate that our approach is capable of aligning the distribution of risk predictions conditioned on the outcome across several groups simultaneously for models built from high-dimensional EHR data. We also discuss the relevance of these results in the context of the empirical trade-off between fairness and model performance.



rate research

Read More

We train and validate a semi-supervised, multi-task LSTM on 57,675 person-weeks of data from off-the-shelf wearable heart rate sensors, showing high accuracy at detecting multiple medical conditions, including diabetes (0.8451), high cholesterol (0.7441), high blood pressure (0.8086), and sleep apnea (0.8298). We compare two semi-supervised train- ing methods, semi-supervised sequence learning and heuristic pretraining, and show they outperform hand-engineered biomarkers from the medical literature. We believe our work suggests a new approach to patient risk stratification based on cardiovascular risk scores derived from popular wearables such as Fitbit, Apple Watch, or Android Wear.
Genome-wide association studies (GWAS) offer new opportunities to identify genetic risk factors for Alzheimers disease (AD). Recently, collaborative efforts across different institutions emerged that enhance the power of many existing techniques on individual institution data. However, a major barrier to collaborative studies of GWAS is that many institutions need to preserve individual data privacy. To address this challenge, we propose a novel distributed framework, termed Local Query Model (LQM) to detect risk SNPs for AD across multiple research institutions. To accelerate the learning process, we propose a Distributed Enhanced Dual Polytope Projection (D-EDPP) screening rule to identify irrelevant features and remove them from the optimization. To the best of our knowledge, this is the first successful run of the computationally intensive model selection procedure to learn a consistent model across different institutions without compromising their privacy while ranking the SNPs that may collectively affect AD. Empirical studies are conducted on 809 subjects with 5.9 million SNP features which are distributed across three individual institutions. D-EDPP achieved a 66-fold speed-up by effectively identifying irrelevant features.
Genome-wide association studies (GWAS) have achieved great success in the genetic study of Alzheimers disease (AD). Collaborative imaging genetics studies across different research institutions show the effectiveness of detecting genetic risk factors. However, the high dimensionality of GWAS data poses significant challenges in detecting risk SNPs for AD. Selecting relevant features is crucial in predicting the response variable. In this study, we propose a novel Distributed Feature Selection Framework (DFSF) to conduct the large-scale imaging genetics studies across multiple institutions. To speed up the learning process, we propose a family of distributed group Lasso screening rules to identify irrelevant features and remove them from the optimization. Then we select the relevant group features by performing the group Lasso feature selection process in a sequence of parameters. Finally, we employ the stability selection to rank the top risk SNPs that might help detect the early stage of AD. To the best of our knowledge, this is the first distributed feature selection model integrated with group Lasso feature selection as well as detecting the risk genetic factors across multiple research institutions system. Empirical studies are conducted on 809 subjects with 5.9 million SNPs which are distributed across several individual institutions, demonstrating the efficiency and effectiveness of the proposed method.
In this paper, we propose FairNN a neural network that performs joint feature representation and classification for fairness-aware learning. Our approach optimizes a multi-objective loss function in which (a) learns a fair representation by suppressing protected attributes (b) maintains the information content by minimizing a reconstruction loss and (c) allows for solving a classification task in a fair manner by minimizing the classification error and respecting the equalized odds-based fairness regularized. Our experiments on a variety of datasets demonstrate that such a joint approach is superior to separate treatment of unfairness in representation learning or supervised learning. Additionally, our regularizers can be adaptively weighted to balance the different components of the loss function, thus allowing for a very general framework for conjoint fair representation learning and decision making.
The use of machine learning systems to support decision making in healthcare raises questions as to what extent these systems may introduce or exacerbate disparities in care for historically underrepresented and mistreated groups, due to biases implicitly embedded in observational data in electronic health records. To address this problem in the context of clinical risk prediction models, we develop an augmented counterfactual fairness criteria to extend the group fairness criteria of equalized odds to an individual level. We do so by requiring that the same prediction be made for a patient, and a counterfactual patient resulting from changing a sensitive attribute, if the factual and counterfactual outcomes do not differ. We investigate the extent to which the augmented counterfactual fairness criteria may be applied to develop fair models for prolonged inpatient length of stay and mortality with observational electronic health records data. As the fairness criteria is ill-defined without knowledge of the data generating process, we use a variational autoencoder to perform counterfactual inference in the context of an assumed causal graph. While our technique provides a means to trade off maintenance of fairness with reduction in predictive performance in the context of a learned generative model, further work is needed to assess the generality of this approach.

suggested questions

comments
Fetching comments Fetching comments
mircosoft-partner

هل ترغب بارسال اشعارات عن اخر التحديثات في شمرا-اكاديميا